Tarbox Family Office’s GenMark Diagnostics, Inc GNMK Stock Holding History

Tarbox Family Office’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-69	Closed	-$2K	–	1246
2021 Q1	$2K	Buy	+69	New	+$1.28K	﹤0.01%	981

Tarbox Family Office's GNMK Position: Q2 2021 in Review

Tarbox Family Office sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 69 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Tarbox Family Office reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Tarbox Family Office sold 69 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $2K.
Tarbox Family Office first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Tarbox Family Office's GenMark Diagnostics, Inc position peaked at $2K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Tarbox Family Office's 13F filing for Q2 2021, filed 16 Jul 2021.